103 related articles for article (PubMed ID: 10580961)
21. Dual-phase helical CT of the liver: value of arterial phase scans in the detection of small (< or = 1.5 cm) malignant hepatic neoplasms.
Hollett MD; Jeffrey RB; Nino-Murcia M; Jorgensen MJ; Harris DP
AJR Am J Roentgenol; 1995 Apr; 164(4):879-84. PubMed ID: 7726040
[TBL] [Abstract][Full Text] [Related]
22. Hypervascular liver metastases: do unenhanced and hepatic arterial phase CT images affect tumor detection?
Oliver JH; Baron RL; Federle MP; Jones BC; Sheng R
Radiology; 1997 Dec; 205(3):709-15. PubMed ID: 9393525
[TBL] [Abstract][Full Text] [Related]
23. Comparison of unenhanced, hepatic arterial-dominant, and portal venous-dominant phase helical CT for the detection of liver metastases in women with breast carcinoma.
Sheafor DH; Frederick MG; Paulson EK; Keogan MT; DeLong DM; Nelson RC
AJR Am J Roentgenol; 1999 Apr; 172(4):961-8. PubMed ID: 10587129
[TBL] [Abstract][Full Text] [Related]
24. [The computed tomography of colorectal tumors with water as the contrast medium].
Gaa J; Deininger HK
Rofo; 1990 Jun; 152(6):723-6. PubMed ID: 2163082
[TBL] [Abstract][Full Text] [Related]
25. Hepatic CT enhancement: comparison of ionic and nonionic contrast agents in the same patients.
Chambers TP; Baron RL; Lush RM; Dodd GD; Miller WJ
Radiology; 1994 Mar; 190(3):721-5. PubMed ID: 8115618
[TBL] [Abstract][Full Text] [Related]
26. Contrast enhancement technique for dynamic hepatic computed tomographic scanning.
Foley WD; Berland LL; Lawson TL; Smith DF; Thorsen MK
Radiology; 1983 Jun; 147(3):797-803. PubMed ID: 6844616
[TBL] [Abstract][Full Text] [Related]
27. Hepatic metastasis detection: comparison of three CT contrast enhancement methods.
Miller DL; Simmons JT; Chang R; Ward BA; Shawker TH; Doppman JL; Chang AE
Radiology; 1987 Dec; 165(3):785-90. PubMed ID: 3685361
[TBL] [Abstract][Full Text] [Related]
28. Mangafodipir trisodium-enhanced MRI for the detection and characterization of focal hepatic lesions: is delayed imaging useful?
Chung JJ; Kim MJ; Kim KW
J Magn Reson Imaging; 2006 May; 23(5):706-11. PubMed ID: 16565954
[TBL] [Abstract][Full Text] [Related]
29. Portal-phase contrast-enhanced helical CT for the detection of malignant hepatic tumors: sensitivity based on comparison with intraoperative and pathologic findings.
Kuszyk BS; Bluemke DA; Urban BA; Choti MA; Hruban RH; Sitzmann JV; Fishman EK
AJR Am J Roentgenol; 1996 Jan; 166(1):91-5. PubMed ID: 8571914
[TBL] [Abstract][Full Text] [Related]
30. Optimal Phase of Dynamic Computed Tomography for Reliable Size Measurement of Metastatic Neuroendocrine Tumors of the Liver: Comparison between Pre- and Post-Contrast Phases.
Huh J; Park J; Kim KW; Kim HJ; Lee JS; Lee JH; Jeong YK; Shinagare AB; Ramaiya NH
Korean J Radiol; 2018; 19(6):1066-1076. PubMed ID: 30386138
[TBL] [Abstract][Full Text] [Related]
31. Detection of focal liver lesions: CT of the hepatobiliary system with gadoxetic acid disodium, or Gd-EOB-DTPA.
Schmitz SA; Häberle JH; Balzer T; Shamsi K; Boese-Landgraf J; Wolf KJ
Radiology; 1997 Feb; 202(2):399-405. PubMed ID: 9015065
[TBL] [Abstract][Full Text] [Related]
32. Hepatic dynamic sequential CT: section enhancement profiles with a bolus of ionic and nonionic contrast agents.
Nelson RC; Moyers JH; Chezmar JL; Hoel MJ; Jones EC; Peterson JE; Cork RD; Bernardino ME
Radiology; 1991 Feb; 178(2):499-502. PubMed ID: 1987614
[TBL] [Abstract][Full Text] [Related]
33. Contrast-enhanced CT of the liver and spleen: comparison of ionic and nonionic contrast agents.
Nelson RC; Chezmar JL; Peterson JE; Bernardino ME
AJR Am J Roentgenol; 1989 Nov; 153(5):973-6. PubMed ID: 2801447
[TBL] [Abstract][Full Text] [Related]
34. Liver metastases: early detection based on abnormal contrast material enhancement at dual-phase helical CT.
Platt JF; Francis IR; Ellis JH; Reige KA
Radiology; 1997 Oct; 205(1):49-53. PubMed ID: 9314961
[TBL] [Abstract][Full Text] [Related]
35. Detection of colorectal cancer hepatic metastases with contrast-enhanced ultrasound: comparison with conventional B-mode ultrasound.
Yarmenitis SD; Karantanas A; Bakantaki A; Papantoniou Y; Gourtsoyiannis N
Dig Dis; 2007; 25(1):86-93. PubMed ID: 17384513
[TBL] [Abstract][Full Text] [Related]
36. Suitability of semi-automated tumor response assessment of liver metastases using a dedicated software package.
Kalkmann J; Ladd SC; de Greiff A; Forsting M; Stattaus J
Rofo; 2010 Jul; 182(7):581-8. PubMed ID: 20419616
[TBL] [Abstract][Full Text] [Related]
37. CT densities in delayed iodine hepatic scanning.
Perkerson RB; Erwin BC; Baumgartner BR; Phillips VM; Torres WE; Clements JL; Gedgaudas-McClees K; Bernardino ME
Radiology; 1985 May; 155(2):445-6. PubMed ID: 3983398
[TBL] [Abstract][Full Text] [Related]
38. Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings.
Abdel-Nabi H; Doerr RJ; Lamonica DM; Cronin VR; Galantowicz PJ; Carbone GM; Spaulding MB
Radiology; 1998 Mar; 206(3):755-60. PubMed ID: 9494497
[TBL] [Abstract][Full Text] [Related]
39. Incremental value of liver MR imaging in patients with potentially curable colorectal hepatic metastasis detected at CT: a prospective comparison of diffusion-weighted imaging, gadoxetic acid-enhanced MR imaging, and a combination of both MR techniques.
Kim HJ; Lee SS; Byun JH; Kim JC; Yu CS; Park SH; Kim AY; Ha HK
Radiology; 2015 Mar; 274(3):712-22. PubMed ID: 25286324
[TBL] [Abstract][Full Text] [Related]
40. Helical CT of the liver: value of an early hepatic arterial phase.
Bonaldi VM; Bret PM; Reinhold C; Atri M
Radiology; 1995 Nov; 197(2):357-63. PubMed ID: 7480677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
